We use a data-driven approach to identify unknowns and build systematic "biomaps" to solve the questions.
We are currently focused on several disease areas, including but not limited to immuno-oncology (e.g., liver cancer, lung cancer, and gastrointestinal tumors), fibrosis (e.g., liver fibrosis, pulmonary fibrosis, and renal fibrosis), autoimmune diseases (e.g., rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, and systemic lupus erythematosus), and aging-associated changes of the immune system.Learn More →
Data-driven Drug Discovery
With a long-term vision and a strong funding, we are committed to bringing in first-in-class medicine to unmet medical needs for patients by applying modern A.I./Data science to the entire life cycle of drug discovery.Learn More →
We are a team of world-renowned scientists who have extensive expertise in disease biology, bioinformatics, machine learning/deep learning, and antibody engineering.Learn More →